Strongbridge Biopharma plc.
SBBP
SBBP was delisted on the 5th of October, 2021.
19 hedge funds and large institutions have $99.4M invested in Strongbridge Biopharma plc. in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
93% more capital invested
Capital invested by funds: $51.6M → $99.4M (+$47.8M)
6% more funds holding
Funds holding: 18 → 19 (+1)
1.63% less ownership
Funds ownership: 60.84% → 59.21% (-1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$5.02M |
| 2 |
BC
Broadfin Capital
New York
|
+$267K |
| 3 |
BlackRock
New York
|
+$106K |
| 4 |
Millennium Management
New York
|
+$67.3K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$61.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$5.47M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$221K |
| 3 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$35.5K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1K |
SBBP Hedge Fund Activity: Q1 2017 in Review
19 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Strongbridge Biopharma plc. (SBBP) for Q1 2017, worth a combined $99.4M — up 93% from $51.6M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new SBBP positions and 4 closed out — a net gain of 5 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $5.02M. The largest seller was RA Capital Management, exiting entirely with an estimated $5.47M sold.
- 19 institutional investors held Strongbridge Biopharma plc. (SBBP) as of Q1 2017, up from 18 in Q4 2016.
- Funds reported $99.4M of Strongbridge Biopharma plc. stock for Q1 2017, up 93% quarter-over-quarter.
- 9 funds opened new Strongbridge Biopharma plc. positions in Q1 2017 and 4 closed out, a net change of +5 holders.
- The largest Strongbridge Biopharma plc. buyer in Q1 2017 was Armistice Capital, an estimated $5.02M added.
- The largest Strongbridge Biopharma plc. seller in Q1 2017 was RA Capital Management, an estimated $5.47M sold.
Based on aggregated 13F filings for Q1 2017.